| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |